Case 1
A 53-year-old man presented with a long history of manic-depressive psychosis, manic type, having been treated with lithium carbonate consistently for over six years. Six weeks previously he had been discharged from a private psychiatric hospital in a nearby metropolitan area with the following prescribed medications: lithium carbonate 300 mg, t.i.d., perphenazine 8 mg, q.i.d., benztropine 2 mg, q.d., and furosemide 20 mg, q.d. His family had come for advice regarding permanent custodial nursinghome care for the patient, who presented with an 8 to 10 week history of a confusional state, periodic hypersomnolence, ataxia with frequent falling, slurred speech, total disorientation withdrawal and marked progressive deteriorat ion of personal habits. The family had received a professional opinion during private psychiatric hospitalization which indicated that his illness was irreversible.
Local hospitalization for an acute brain syndrome work-up was advised. Briefly, all studies were negative, including a RISA Cisternograph, with the exception of the electroencephalograms which were abnormal, showing diffuse slow activity. Admission serum lithium level was 0.72 meq. per L. All medications except the lithium were immediately discontinued without apparent change of behavioural status. Subsequently lithium was discontinued; within two-and-a-half days the serum lithium level fell This case is similar to a number of previously described acute brain syndromes associated with lithium therapy (1-6, 10), and it confirms that monitoring serum lithium values alone does not always enable detection of imminent toxic effects of the drug (7, 8) . The combination of lithium with diuretic therapy should be questioned.
Case 2
A 49-year-old woman was admitted for treatment of an acute manic psychosis with a past history of three previous hospitalizations but lithium carbonate had not been used. Family history was positive for bipolar affective disorder. She was initially treated with thioridazine, up to 800 mg per day, with modest control of her mania. On the sixth hospital day the medication was changed to haloperidol 40 mg per day and lithium carbonate 1500 mg per day. On the twelfth day she suddenly developed hyperthermia to 105.6°F., leukocytosis of 20,000 with a normal differential count and hematuria. She was transferred to the intensive care unit, with a severe and protracted impairment of consciousness, restless movement in bed, muscular rigidity, hyperactive tendon reflexes, coarse tremor, fasciculations and symmetrical clonic contractions of large muscle groups (which seemed to be relieved by I. V. diazepam). After approximately three days of supportive treatment, she showed progressive improvement without residual symptoms. Serum lithium level was I. I meq per L on day eleven, 2.3 meq per L on day thirteen, 0.5 on day fourteen; day sixteen it was O. I rneq per L, and none was detectable on day seventeen. The latter report presents a case of acute, severe poisoning from lithium carbonate. Schou has reported eight similar cases, three of whom died (11). Von Hartitzsch reported two cases which survived with permanent neurological damage (13). The early case reports of Corcoran and Hanlon include three deaths (2, 5) . Van der Velde (12) reported three similar cases, which shows how fortunate the two patients reported here were to survive without residual impairment.
Experience with Case 2 supports Flemenbaum in his recommendation that acute manic episodes are best treated with emphasis on phenothiazines or butyrophenones, and with conservative avoidance of aggressive lithium administration (4) . For those who may encounter a similar case, the beneficial effect of urea infusion and aminophylline on renal lithium elimination in man is suggested (9) .
Summary
Two cases of toxic reaction to lithium carbonate are reported. The first patient displayed symptoms resembling those of organic brain syndrome which was not associated with a high serum lithium level. The influence of diuretic therapy in combination with lithium is felt to enhance the risk of intoxication. The second case depicts acute CNS toxicity with known fatal potential. Conservative lithium administration is recommended for acute manic psychosis and reference is made to the beneficial effects of urea and aminophylline on renal lithium elimination in the active treatment of lithium poisoning.
